Table 3.
Cytotoxicity of synthesized zinc oxide nanoparticles.
S. no. | Sample (μg/mL) | Cell visibility (%) |
---|---|---|
1 | Fluoxetine | +ve control |
2 | DMSO | −ve control |
3 | 1.0 | 1.51 |
4 | 3.0 | 2.6 |
5 | 5.0 | 3.0 |
6 | 7.0 | 4.1 |
7 | 9.0 | 5.7 |
8 | 11 | 8.4 |
Cytotoxicity of synthesized zinc oxide nanoparticles.
S. no. | Sample (μg/mL) | Cell visibility (%) |
---|---|---|
1 | Fluoxetine | +ve control |
2 | DMSO | −ve control |
3 | 1.0 | 1.51 |
4 | 3.0 | 2.6 |
5 | 5.0 | 3.0 |
6 | 7.0 | 4.1 |
7 | 9.0 | 5.7 |
8 | 11 | 8.4 |